Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 2
1978 1
1979 3
1983 1
1995 1
1997 1
2002 1
2004 2
2005 7
2006 5
2007 11
2008 4
2009 7
2010 7
2011 4
2012 10
2013 8
2014 16
2015 12
2016 10
2017 7
2018 15
2019 7
2020 26
2021 32
2022 21
2023 17
2024 31
2025 25

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

267 results

Results by year

Filters applied: . Clear all
Page 1
Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2).
Wollenberg A, Blauvelt A, Guttman-Yassky E, Worm M, Lynde C, Lacour JP, Spelman L, Katoh N, Saeki H, Poulin Y, Lesiak A, Kircik L, Cho SH, Herranz P, Cork MJ, Peris K, Steffensen LA, Bang B, Kuznetsova A, Jensen TN, Østerdal ML, Simpson EL; ECZTRA 1 and ECZTRA 2 study investigators. Wollenberg A, et al. Among authors: lesiak a. Br J Dermatol. 2021 Mar;184(3):437-449. doi: 10.1111/bjd.19574. Epub 2020 Dec 30. Br J Dermatol. 2021. PMID: 33000465 Free PMC article. Clinical Trial.
Scleroderma and scleroderma-like syndromes.
Romanowska-Próchnicka K, Dziewit M, Lesiak A, Reich A, Olesińska M. Romanowska-Próchnicka K, et al. Among authors: lesiak a. Front Immunol. 2024 Jun 3;15:1351675. doi: 10.3389/fimmu.2024.1351675. eCollection 2024. Front Immunol. 2024. PMID: 38887288 Free PMC article. Review.
Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials.
Bissonnette R, Warren RB, Pinter A, Agner T, Gooderham M, Schuttelaar MLA, Crépy MN, Stingeni L, Serra-Baldrich E, Baranowski K, Korn S, Kurvits M, Plohberger U, Strange Vest N, Schliemann S; trial investigators. Bissonnette R, et al. Lancet. 2024 Aug 3;404(10451):461-473. doi: 10.1016/S0140-6736(24)01027-4. Epub 2024 Jul 18. Lancet. 2024. PMID: 39033766 Clinical Trial.
Optimal sunscreen use, during a sun holiday with a very high ultraviolet index, allows vitamin D synthesis without sunburn.
Young AR, Narbutt J, Harrison GI, Lawrence KP, Bell M, O'Connor C, Olsen P, Grys K, Baczynska KA, Rogowski-Tylman M, Wulf HC, Lesiak A, Philipsen PA. Young AR, et al. Among authors: lesiak a. Br J Dermatol. 2019 Nov;181(5):1052-1062. doi: 10.1111/bjd.17888. Epub 2019 May 24. Br J Dermatol. 2019. PMID: 31069787 Free PMC article. Clinical Trial.
Double-blind, randomized controlled trial comparing the use of microneedling alone versus chemical peeling alone versus a combination of microneedling and chemical peeling in the treatment of atrophic post-acne scars. An assessment of clinical effectiveness and patients' quality-of-life.
Pakla-Misiur A, Grochowiec M, Lesiak A, Bednarski IA. Pakla-Misiur A, et al. Among authors: lesiak a. Postepy Dermatol Alergol. 2021 Aug;38(4):629-635. doi: 10.5114/ada.2021.108913. Epub 2021 Sep 17. Postepy Dermatol Alergol. 2021. PMID: 34658706 Free PMC article.
Enoxaparin-induced eruptive angiokeratomas.
Niedźwiedź M, Żebrowska A, Lesiak A, Narbutt J, Skibińska M. Niedźwiedź M, et al. Among authors: lesiak a. Pol Arch Intern Med. 2023 May 23;133(5):16463. doi: 10.20452/pamw.16463. Epub 2023 Mar 14. Pol Arch Intern Med. 2023. PMID: 36916492 Free article. No abstract available.
Long-term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO-LT phase 3, open-label study.
Tziotzios C, Sinclair R, Lesiak A, Mehlis S, Kinoshita-Ise M, Tsianakas A, Luo X, Law EH, Ishowo-Adejumo R, Wolk R, Sadrarhami M, Lejeune A. Tziotzios C, et al. Among authors: lesiak a. J Eur Acad Dermatol Venereol. 2025 Jun;39(6):1152-1162. doi: 10.1111/jdv.20526. Epub 2025 Jan 23. J Eur Acad Dermatol Venereol. 2025. PMID: 39846397 Free PMC article. Clinical Trial.
Antimicrobial activity of metal-based nanoparticles: a mini-review.
Hancharova M, Halicka-Stępień K, Dupla A, Lesiak A, Sołoducho J, Cabaj J. Hancharova M, et al. Among authors: lesiak a. Biometals. 2024 Aug;37(4):773-801. doi: 10.1007/s10534-023-00573-y. Epub 2024 Jan 29. Biometals. 2024. PMID: 38286956 Review.
267 results